Rafael Coveñas (R Coveñas)

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 21

Top Topics

Acute Myeloid Leukemia

Endometrial Cancer

Radical Prostatectomy

Top Venues

International journal of molecular sciences

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Rafael Coveñas
Editorial for the Special Issue "Current Research on Cancer Biology and Therapeutics". International journal of molecular sciences 25 (5) (2024)
Manuel Lisardo Sánchez, Arturo Mangas, Rafael Coveñas
Glioma and Peptidergic Systems: Oncogenic and Anticancer Peptides. International journal of molecular sciences 25 (14) (2024)
Rafael Coveñas
Editorial for the Special Issue "Current Research on Cancer Biology and Therapeutics". International journal of molecular sciences 25 (5) (2024)
Manuel Lisardo Sánchez, Arturo Mangas, Rafael Coveñas
Glioma and Peptidergic Systems: Oncogenic and Anticancer Peptides. International journal of molecular sciences 25 (14) (2024)
Manuel Lisardo Sánchez, Arturo Mangas, Rafael Coveñas
Glioma and Peptidergic Systems: Oncogenic and Anticancer Peptides. International journal of molecular sciences 25 (14) (2024)
Rafael Coveñas
Editorial for the Special Issue "Current Research on Cancer Biology and Therapeutics". International journal of molecular sciences 25 (5) (2024)
Francisco David Rodriguez, Manuel Lisardo Sánchez, Rafael Coveñas
Neurotensin and Alcohol Use Disorders: Towards a Pharmacological Treatment. International journal of molecular sciences 24 (10) (2023)
Manuel Lisardo Sánchez, Francisco David Rodriguez, Rafael Coveñas
Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies. International journal of molecular sciences 24 (12) (2023)
Francisco David Rodriguez, Rafael Coveñas
Peptidergic Systems as Antitumor Targets: A Right Direction to Fight Cancer? Cancers 15 (20) (2023)
Manuel Lisardo Sánchez, Francisco David Rodriguez, Rafael Coveñas
Peptidergic Systems and Cancer: Focus on Tachykinin and Calcitonin/Calcitonin Gene-Related Peptide Families. Cancers 15 (6) (2023)
Manuel Lisardo Sánchez, Francisco David Rodriguez, Rafael Coveñas
Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies. International journal of molecular sciences 24 (12) (2023)
Rafael Coveñas, Francisco David Rodriguez, Prema Robinson, Miguel Muñoz
The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant. International journal of molecular sciences 24 (21) (2023)
Manuel Lisardo Sánchez, Francisco David Rodriguez, Rafael Coveñas
Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies. International journal of molecular sciences 24 (12) (2023)
Manuel Lisardo Sánchez, Francisco David Rodriguez, Rafael Coveñas
Involvement of the Opioid Peptide Family in Cancer Progression. Biomedicines 11 (7) (2023)
Manuel Lisardo Sánchez, Francisco David Rodriguez, Rafael Coveñas
Peptidergic Systems and Cancer: Focus on Tachykinin and Calcitonin/Calcitonin Gene-Related Peptide Families. Cancers 15 (6) (2023)
Manuel Lisardo Sánchez, Rafael Coveñas
The Galaninergic System: A Target for Cancer Treatment. Cancers 14 (15) (2022)
Mario F Muñoz-Pinto, Sandro Argüelles, Marisa Rosso, Rafael Medina, Rafael Coveñas, Antonio Ayala, Miguel Muñoz
The Neurokinin-1 Receptor Is Essential for the Viability of Human Glioma Cells: A Possible Target for Treating Glioblastoma. BioMed research international 2022 (2022)
Rafael Coveñas, Miguel Muñoz
Involvement of the Substance P/Neurokinin-1 Receptor System in Cancer. Cancers 14 (14) (2022)
Maria Del Pilar Marcos Rabal, Rafael Coveñas
Neuropeptidergic Control of Feeding: Focus on the Galanin Family of Peptides. International journal of molecular sciences 22 (5) (2021)
Miguel Muñoz, Rafael Coveñas
The Neurokinin-1 Receptor Antagonist Aprepitant: An Intelligent Bullet against Cancer? Cancers 12 (9) (2020)
Miguel Muñoz, Rafael Coveñas
The Neurokinin-1 Receptor Antagonist Aprepitant, a New Drug for the Treatment of Hematological Malignancies: Focus on Acute Myeloid Leukemia. Journal of clinical medicine 9 (6) (2020)
Laetitia Vidal, Véronique Thuault, Arturo Mangas, Rafael Coveñas, Anne Thienpont, Michel Geffard
Lauryl-poly-L-lysine: A New Antimicrobial Agent? Journal of amino acids 2014 (2014)